Technology News and Research

RSS

Study provides details on genetics behind many metabolic diseases

In what is so far the largest investigation of its kind, researchers uncovered a wide range of new insights about common diseases and how they are affected by differences between two persons' genes. The results from this study could lead to highly targeted, individualized therapies.

27 Oct 2011

BGI, UC Davis partner to create new sequencing facility in Sacramento

The University of California, Davis, and BGI, the world's largest genomic institute, based in China, have signed a historic agreement that will change the landscape of genomic sciences in California and the Western states, and foster critical breakthroughs in the areas of food security and human, animal and environmental health.

27 Oct 2011

Research questions aromatherapy safety

Aromatherapy oils are relied upon to relax, reduce stress and soothe aches and pains by many. However researchers from Chia-Nan University of Pharmacy and Science Tainan, Taiwan say these oils may not be completely harmless.

24 Oct 2011

Three dry days a week reduces risk of alcohol related liver disease

The Royal College of Physicians said the present official guidance on healthy drinking limits is ‘extremely dangerous’ and must be rewritten – because it implies that drinking every day is fine. Government advice states men should drink no more than four units a day and women no more than three.

24 Oct 2011

Abzyme Therapeutics licenses SUMOpro from LifeSensors

Abzyme Therapeutics, a new biotechnology company dedicated to developing methods to generate human monoclonal antibodies for the treatment of disease, announced today that they have entered into an exclusive agreement with LifeSensors to license their proprietary protein expression platform, SUMOpro™. Enhanced protein expression is key to the evolution and development of antibodies and the LifeSensors

24 Oct 2011

Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research

Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have entered into an agreement to co-develop and co-promote pre-clinical oncology in vivo solutions for researchers worldwide. The agreement provides researchers with improved access to a large, diverse portfolio of translational models for use in pre-clinical oncology studies, along with supporting scientific services.

24 Oct 2011

Leica Microsystems introduces complete case management solution for digital pathology at Pathology Visions

Leica Microsystems announce the launch of its clinical workflow solution for Digital Pathology at Pathology Visions 2011. Digital Image Hub Enterprise* with its powerful image management, integration and communication capabilities, in conjunction with a new high performance, intuitive client viewer, SlidePath Gateway*, combine to make this the ideal solution for clinical centers moving towards true Digital Pathology implementation. Furthermore, Leica’s Total Digital Pathology solutions now provide an implementation of the DICOM Supplement 145 standard for both slide scanning and viewing.

24 Oct 2011

Bio-Images and Medimetrics partner to deliver the next generation of smart pill technology

Bio-Images Research and Medimetrics Personalized Drug Delivery have today announced a partnership to introduce the IntelliCap to the global pharmaceutical industry as a clinical research tool. The announcement was made at the annual meeting of the American Association of Pharmaceutical Scientists, being held in Washington DC, USA, between 23 and 27 October 2011.

24 Oct 2011

Invuity's illuminated breast retractor system helps surgeons to better visualize delicate structures

Invuity, a leading developer of state-of-the-art illuminated surgical technology, today introduced its illuminated breast retractor system at the American College of Surgeons' 97th Annual Clinical Congress in San Francisco.

24 Oct 2011

Zirmed releases Patient Payment Developer Kit

ZirMed, a leading provider of revenue cycle management solutions for healthcare providers, today announced the release of the ZirMed Patient Payment Developer Kit, a new partner integration toolkit allowing provider and software vendors to seamlessly leverage ZirMed's Online Bill Pay, Virtual Terminal, and payment processing services.

24 Oct 2011

external Trigeminal Nerve Stimulation pediatric clinical trial for ADHD receives NeuroSigma funding

NeuroSigma, Inc., a Los Angeles-based medical technology company, announced today that it has signed a contract with the University of California, Los Angeles (UCLA) to fund a Phase I pediatric clinical trial to study the use of non-invasive, external Trigeminal Nerve Stimulation (TNS) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

24 Oct 2011

Older adults with glaucoma at increased risk of falls

Older adults with glaucoma are at increased risk of falls resulting in injury, reports a study in the November issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

24 Oct 2011

Some states limit Medicaid hospital coverage; Food stamp, benefit systems revamped

States, facing budget shortfalls, look for ways to save money on their Medicaid programs, including limiting hospital stays for enrollees. Wisconsin is holding hearings on plans to alter the programs there, and California is looking at restructuring the way health care is delivered to people who qualify for both Medicare and Medicaid. Meanwhile, Stateline reports that a number of states are using new technology to run their benefits programs.

24 Oct 2011

DNA synbodies, a new class of affinity reagents, gets major NIH boost

An ongoing Arizona State University effort to develop a revolutionary class of reagents that holds great promise for the future of medicine has received a major boost with a three-year, $4 million award from the National Institutes of Health.

24 Oct 2011

NCI awards Metabolomx SBIR contract to develop sensor array system for detecting lung cancer

Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, today announced the Company was awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined Phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.

24 Oct 2011

Holes appearing in some states' safety nets for disabled, seniors; Ohio referendum looms

Health care news from Georgia, Ohio, California, Wisconsin, Florida, Iowa, Massachusetts and Texas.

24 Oct 2011

US markets for neurosurgical and neurovascular devices to grow to $240 million by 2016

According to Millennium Research Group, the global authority on medical technology market intelligence, the market for the specialized devices used for neurosurgical and neurovascular treatments will grow to $240 million by 2016, driven largely by an aging population in the United States that will suffer an increasing incidence of conditions such as stroke, cerebral aneurysms and intracranial atherosclerosis disease.

From Medtronic 24 Oct 2011

CryoLife begins enrollment in BioFoam Surgical Matrix IDE clinical trial

CryoLife, Inc.,, a leading tissue processing and medical device Company focused on cardiac and vascular surgery, today announced that it has enrolled the first patient in its U.S. Investigational Device Exemption (IDE) clinical trial for its BioFoam® Surgical Matrix protein hydrogel technology. In connection with the trial, BioFoam will be used as an adjunct to conservative measures of achieving hemostasis on newly resected liver parenchyma.

24 Oct 2011

More exposure to natural light may reduce rates of nearsightedness

A new analysis of recent eye health studies shows that more time spent outdoors is related to reduced rates of nearsightedness, also known as myopia, in children and adolescents. Myopia is much more common today in the United States and many other countries than it was in the 1970s. In parts of Asia, more than 80 percent of the population is nearsighted.

24 Oct 2011

Zynex ranked 127th on Deloitte's 2011 Technology Fast 500 list

Zynex, Inc., a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that it has been ranked 127th on Deloitte's 2011 Technology Fast 500 list for revenue growth between 2006 and 2010.

24 Oct 2011

Technology News and Research

Study provides details on genetics behind many metabolic diseases

BGI, UC Davis partner to create new sequencing facility in Sacramento

Research questions aromatherapy safety

Three dry days a week reduces risk of alcohol related liver disease

Abzyme Therapeutics licenses SUMOpro from LifeSensors

Taconic and Oncodesign announce agreement to co-promote and co-develop solutions to advance oncology research

Leica Microsystems introduces complete case management solution for digital pathology at Pathology Visions

Bio-Images and Medimetrics partner to deliver the next generation of smart pill technology

Invuity's illuminated breast retractor system helps surgeons to better visualize delicate structures

Zirmed releases Patient Payment Developer Kit

external Trigeminal Nerve Stimulation pediatric clinical trial for ADHD receives NeuroSigma funding

Older adults with glaucoma at increased risk of falls

Some states limit Medicaid hospital coverage; Food stamp, benefit systems revamped

DNA synbodies, a new class of affinity reagents, gets major NIH boost

NCI awards Metabolomx SBIR contract to develop sensor array system for detecting lung cancer

Holes appearing in some states' safety nets for disabled, seniors; Ohio referendum looms

US markets for neurosurgical and neurovascular devices to grow to $240 million by 2016

CryoLife begins enrollment in BioFoam Surgical Matrix IDE clinical trial

More exposure to natural light may reduce rates of nearsightedness

Zynex ranked 127th on Deloitte's 2011 Technology Fast 500 list

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News